Murag S, Ahmed A, Kim D. Recent epidemiology of nonalcoholic fatty liver disease. Gut Liver. 2021;15(2):206–16.

Article  PubMed  Google Scholar 

Konyn P, Ahmed A, Kim D. Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023;29(Suppl):S43–57.

Article  PubMed  Google Scholar 

Simon TG, Roelstraete B, Hagström H, Sundström J, Ludvigsson JF. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. Gut. 2022;71(9):1867–75.

Article  PubMed  Google Scholar 

Mantovani A, Csermely A, Petracca G, Beatrice G, Corey KE, Simon TG, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(11):903–13.

Article  PubMed  Google Scholar 

Mantovani A, Byrne CD, Benfari G, Bonapace S, Simon TG, Targher G. Risk of Heart failure in patients with nonalcoholic fatty liver disease: JACC Review topic of the Week. J Am Coll Cardiol. 2022;79(2):180–91.

Article  CAS  PubMed  Google Scholar 

Tang ASP, Chan KE, Quek J, Xiao J, Tay P, Teng M, Lee KS, Lin SY, Myint MZ, Tan B, et al. Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: an updated meta-analysis with 135,602 individuals. Clin Mol Hepatol. 2022;28(3):483–96.

Article  PubMed  PubMed Central  Google Scholar 

Valbusa F, Agnoletti D, Scala L, Grillo C, Arduini P, Bonapace S, Calabria S, Scaturro G, Mantovani A, Zoppini G, et al. Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure. Int J Cardiol. 2018;265:162–8.

Article  PubMed  Google Scholar 

Baik M, Kim SU, Kang S, Park HJ, Nam HS, Heo JH, Kim BK, Park JY, Kim DY, Ahn SH, et al. Liver fibrosis, Not Steatosis, associates with long-term outcomes in ischaemic stroke patients. Cerebrovasc Dis. 2019;47(1–2):32–9.

Article  PubMed  Google Scholar 

Archer AJ, Belfield KJ, Orr JG, Gordon FH, Abeysekera KW. EASL clinical practice guidelines: non-invasive liver tests for evaluation of liver disease severity and prognosis. Frontline Gastroenterol. 2022;13(5):436–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.

Article  PubMed  PubMed Central  Google Scholar 

Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57(10):1441–7.

Article  CAS  PubMed  Google Scholar 

Kim JH, Kwon SY, Lee SW, Lee CH. Validation of fatty liver index and lipid accumulation product for predicting fatty liver in Korean population. Liver Int. 2011;31(10):1600–1.

Article  CAS  PubMed  Google Scholar 

Lee YH, Bang H, Park YM, Bae JC, Lee BW, Kang ES, Cha BS, Lee HC, Balkau B, Lee WY, et al. Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores. PLoS ONE. 2014;9(9):e107584.

Article  PubMed  PubMed Central  Google Scholar 

Lee SR, Han KD, Choi EK, Oh S, Lip GYH. Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study. Sci Rep. 2021;11(1):3737.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jaiswal V, Ang SP, Huang H, Momi NK, Hameed M, Naz S, Batra N, Ishak A, Doshi N, Gera A, et al. Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis. J Investig Med. 2023;71(6):591–602.

Article  PubMed  Google Scholar 

Alon L, Corica B, Raparelli V, Cangemi R, Basili S, Proietti M, Romiti GF. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Prev Cardiol. 2022;29(6):938–46.

Article  PubMed  Google Scholar 

Gong H, Liu X, Cheng F. Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: a systematic review and meta-analysis. J Int Med Res. 2021;49(9):3000605211047074.

Article  CAS  PubMed  Google Scholar 

Roh JH, Lee JH, Lee H, Yoon YH, Kim M, Kim YG, Park GM, Park JH, Seong IW. Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults. Liver Int. 2020;40(2):338–46.

Article  PubMed  Google Scholar 

Choi J, Lee SR, Choi EK, Ahn HJ, Kwon S, Park SH, Lee H, Chung J, Han M, Lee SW, et al. Non-alcoholic fatty liver Disease and the risk of incident atrial fibrillation in young adults: a nationwide population-based cohort study. Front Cardiovasc Med. 2022;9:832023.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheol Seong S, Kim YY, Khang YH, Heon Park J, Kang HJ, Lee H, Do CH, Song JS, Hyon Bang J, Ha S, et al. Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017;46(3):799–800.

PubMed  Google Scholar 

Cho EJ, Jung GC, Kwak MS, Yang JI, Yim JY, Yu SJ, Chung GE. Fatty liver index for predicting nonalcoholic fatty liver disease in an asymptomatic Korean population. Diagnostics. 2021;11(12):2233.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim KS, Hong S, Han K, Park CY. Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study. BMJ. 2024;384:e076388.

Article  PubMed  PubMed Central  Google Scholar 

Zhou BG, Ju SY, Mei YZ, Jiang X, Wang M, Zheng AJ, Ding YB. A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation. Front Endocrinol (Lausanne). 2023;14:1160532.

Article  PubMed  Google Scholar 

Ding YH, Ma Y, Qian LY, Xu Q, Wang LH, Huang DS, Zou H. Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targets. Oncotarget. 2017;8(36):60673–83.

Article  PubMed  PubMed Central  Google Scholar 

Haghbin H, Gangwani MK, Ravi SJK, Perisetti A, Aziz M, Goyal H, Nawras A, Sodeman T. Nonalcoholic fatty liver disease and atrial fibrillation: possible pathophysiological links and therapeutic interventions. Ann Gastroenterol. 2020;33(6):603–14.

PubMed  PubMed Central  Google Scholar 

Obi MF, Reinberg Palmar A, Namireddy V, Campos FN, Cho HJ. The liver-heart connection: a literature review of liver disease as a risk factor for atrial fibrillation. Cureus. 2023;15(5):e38536.

PubMed  PubMed Central  Google Scholar 

Rangari M, Sinha S, Kapoor D, Mohan JC, Sarin SK. Prevalence of autonomic dysfunction in cirrhotic and noncirrhotic portal hypertension. Am J Gastroenterol. 2002;97(3):707–13.

Article  PubMed  Google Scholar 

Voigt MD, Trey G, Levitt NS, Raine R, Lombard CJ, Robson SC, Gordon G, Kirsch RE. Autonomic neuropathy in extra-hepatic portal vein thrombosis: evidence for impaired autonomic reflex arc. J Hepatol. 1997;26(3):634–41.

Article  CAS  PubMed  Google Scholar 

Ohno R, Kaneko H, Suzuki Y, Okada A, Matsuoka S, Ueno K, Fujiu K, Michihata N, Jo T, Takeda N, et al. Association of metabolic dysfunction-associated fatty liver disease with risk of HF and AF. JACC Asia. 2023;3(6):908–21.

Article  PubMed  PubMed Central  Google Scholar 

Simon TG, Ebrahimi F, Roelstraete B, Hagström H, Sundström J, Ludvigsson JF. Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study. Cardiovasc Diabetol. 2023;22(1):343.

Article  PubMed  PubMed Central  Google Scholar 

Angulo P, Bugianesi